Published in Law and Health Weekly, March 12th, 2005
"We were not asleep at the wheel, we were actually engaged in reviewing a lot of data," Lourdes Villalba, MD, told a joint meeting of the U.S. Food and Drug Administration (FDA)'s arthritis advisory committee and its drug safety and risk management advisory committee, which are looking into Vioxx, Celebrex and Bextra.
Vioxx was pulled from the market September 30, 2004, by manufacturer...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly